Bergua Burgués, Juan Miguel | Hematología y Hemoterapia |

Resultados: 236
Tipo Título / Nombre Autor(es) Año
Clinical outcomes after CPX-351 in patients with high-risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry Bernal T, Fernández Moreno A, LaIglesia A de, Benavente C..., Bergua Burgués JM 2023
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group Sargas C, Ayala R, Larráyoz MJ, Chillón MC, Rodriguez-Arboli E..., Bergua J, PETHEMA cooperative study group 2023
Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia Simoes C, Villar S, Ariceta B, Garcés JJ, Burgos L..., Bergua JM 2023
Extranodal natural killer/T-cell lymphoma nasal type in a western population: Molecular profiling identifies new therapeutic targets González Barca E, Tomás-Roca L, Esteve A, Rodríguez M, Gato L..., Bergua Burgués JM 2023
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry Sargas C, Ayala R, Larráyoz MJ, Chillón MC..., Bergua JM 2023
Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia Simoes C, Chillon MC, Martínez-Cuadrón D, Calasanz MJ..., Bergua Burgués JM 2023
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4 Kayser S, Martínez-Cuadrón D, Hanoun M, Stölzel F, Gil C..., Burgues JMB 2023
Conventional PCR Versus Next Generation Sequencing for Diagnosis of FLT3, IDH and NPM1 Mutations in Acute Myeloid Leukemia: Interim Analysis of the PCR-LMA Protocol of the Pethema Group Boluda B, Sargas C, Ayala R..., Bergua J 2022
Prognostic Impact of NPM1 and FLT3-ITD Mutations in Patients Treated with Non-Intensive Regimens: A Pethema Registry Study Suárez E, Alonso JM, Boluda B..., Bergua J 2022
Transcriptional and Genomic Characterization of Measurable Residual Disease (MRD) Cells in Acute Myeloid Leukemia (AML) Simoes C, Villar S, Ariceta B..., Bergua J 2022